Valproic acid binding to human serum and human placenta in vitro

Therapeutic Drug Monitoring

Volumn 27, Issue 3, 2005, Pages 375-377

  Bailey, David N ^a,b   Briggs, John R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

Binding; Human placenta; Human serum; Transplacental transfer; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; VALPROATE SEMISODIUM; VALPROIC ACID;

ARTICLE; BINDING AFFINITY; DRUG BINDING; DRUG DIFFUSION; DRUG TRANSPORT; EQUILIBRIUM CONSTANT; HUMAN; HUMAN TISSUE; PLACENTA; PLACENTAL TRANSFER; PRIORITY JOURNAL; SERUM;

BLOOD PROTEINS; FEMALE; HUMANS; MALE; MATERNAL-FETAL EXCHANGE; PLACENTA; PREGNANCY; PROTEIN BINDING; VALPROIC ACID;

EID: 20044394368     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000158077.07836.9a     Document Type: Article

References (13)

1. Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs. 2002;16:695-714.
2. Barzago MM, Bortolotti A, Stellari FF, et al. Placental transfer of valproic acid after liposome encapsulation during in vitro human placenta perfusion. J Pharmacol Exp Ther. 1996;277:79-86.
3. Kultima K, Nystrom AM, Scholz B, et al. Valproic acid teratogenicity: a toxicogenomics approach. Environ Health Perspect. 2004;112:1225-1235.
4. Utoguchi N, Audus KL. Carrier-mediated transport of valproic acid in BeWo cells, a human trophoblast cell line. Int J Pharm. 2000;195:115-124.
5. Barre J, Chamouard JM, Houin G, et al. Equilibrium dialysis, ultrafiltration, and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid. Clin Chem. 1985;31: 60-64.
6. Bailey DN. Cocaine and cocaethylene binding to human placenta. Am J Obstet Gynecol. 1997;177:527-531.
7. Scatchard G. The attractions of proteins for small molecules and ions. Ann NY Acad Sci. 1949;51:660-672.
8. Rosenthal HE. A graphic method for the determination and presentation of binding parameters in a complex system. Anal Biochem. 1967;20:525-532.
9. Bailey DN, Briggs JR. The binding of acetaminophen, lidocaine, and valproic acid to human milk. Am J Clin Pathol. 2004;121:754-757.
10. Felix S, Sproule BA, Hardy BG, et al. Dose-related pharmacokinetics and pharmacodynamics of valproate in the elderly. J Clin Psychopharmacol. 2003;23:471-478.
11. Riva R, Albani F, Contin M, et al. Mechanism of altered drug binding to serum proteins in pregnant women: studies with valproic acid. Ther Drug Monit. 1984;6:25-30.
12. Fowler DW, Eadie MJ, Dickinson RG. Transplacental transfer and biotransformation studies of valproic acid and its glucuronide(s) in the perfused human placenta. J Pharmacol Exp Ther. 1989;249:318-323.
13. Nau H, Scott WJ. Weak acids may act as teratogens by accumulating in the basic milieu of the early mammalian embryo. Nature. 1986;323:276-278.